Illumina Inc Stock Research

Market Summary

USD195.89+2.36

Market Closed

1.22%

ILMN Alerts

1 major insider sales recently.
Big fall in Revenue (Y/Y)

ILMN Stock Price

ILMN RSI Chart

ILMN Valuation

Market Cap

31.0B

Price/Earnings (Trailing)

-7.03

Price/Sales (Trailing)

6.96

EV/EBITDA

-6.86

Price/Free Cashflow

-658.52

ILMN Price/Sales (Trailing)

ILMN Profitability

Operating Margin

64.83%

EBT Margin

-94.59%

Return on Equity

-66.74%

Return on Assets

-35.95%

Free Cashflow Yield

-0.15%

ILMN Fundamentals

ILMN Revenue

Revenue (TTM)

4.4B

Revenue Y/Y

-11.12%

Revenue Q/Q

0.37%

ILMN Earnings

Earnings (TTM)

-4.4B

Earnings Y/Y

-223.01%

Earnings Q/Q

96.36%

Price Action

52 Week Range

173.45258.07

(Low)(High)

Last 7 days

-4.4%

Last 30 days

-7.1%

Last 90 days

-0.4%

Trailing 12 Months

-19.6%

ILMN Financial Health

Current Ratio

1.28

ILMN Investor Care

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-28.51

Peers (Alternatives to Illumina)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
A	35.6B	6.9B	-9.54%	-2.60%	26.94	5.14	7.53%	9.79%
ILMN	31.0B	4.4B	-7.14%	-19.58%	-7.03	6.96	-4.49%	-677.95%
MTD	30.6B	4.0B	-7.76%	7.13%	34.48	7.74	3.66%	11.80%
WAT	15.4B	3.0B	-12.17%	-18.53%	22.33	5.19	3.42%	-2.23%
PKI	14.9B	3.4B	-15.95%	-22.45%	15.51	4.44	-23.30%	29.82%
MID-CAP
SMALL-CAP
PACB	3.1B	128.3M	25.18%	130.68%	-9.72	24.3	-1.69%	-82.99%
ADPT	997.0M	184.3M	-5.67%	-8.72%	-5.11	5.41	19.29%	17.33%
QTRX	778.0M	104.4M	75.74%	23.16%	-9.19	7.45	-7.50%	-28.77%
NSTG	273.6M	132.0M	-35.71%	-63.60%	-1.7	2.07	-8.69%	-26.95%
HBIO	248.1M	114.5M	5.19%	56.80%	-123.18	2.17	-5.10%	69.01%
BNGO	195.4M	29.5M	-11.93%	-58.37%	-1.4	6.62	43.94%	-51.20%
CDXS	164.7M	116.2M	-37.63%	-75.54%	-3.44	1.42	-4.78%	-132.67%
PSNL	90.3M	68.7M	-6.76%	-53.04%	-0.79	1.31	-13.98%	-40.40%
CSBR	68.1M	53.7M	0.52%	-31.14%	-21.83	1.27	14.70%	-1523.74%

Financials for Illumina

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	-3.0%	4,447	4,584	4,699	4,692	4,656
Cost Of Revenue	1.5%	1,636	1,612	1,583	1,523	1,452
Gross Profit	-5.4%	2,811	2,972	3,116	3,169	3,204
Operating Expenses	1.2%	7,238	7,151	7,127	4,068	3,337
S&GA Expenses	5.3%	1,366	1,297	1,290	2,023	2,026
R&D Expenses	1.4%	1,339	1,321	1,325	1,436	1,311
EBITDA	-6.5%	-4,095	-3,846	244	1,162	-
EBITDA Margin	-9.1%	-0.89*	-0.82*	0.05*	0.25*	-
Earnings Before Taxes	-5.1%	-4,555	-4,336	-4,083	9.00	853
EBT Margin	-8.9%	-0.95*	-0.87*	0.00*	0.18*	-
Interest Expenses	57.7%	41.00	26.00	31.00	39.00	49.00
Net Income	-6.1%	-4,404	-4,152	-19.00	701	-
Net Income Margin	-8.7%	-0.96*	-0.88*	0.00*	0.15*	-
Free Cahsflow	-59.1%	106	259	53.00	208	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	-3.6%	11,811	12,252	11,256	15,448	15,274
Current Assets	-10.9%	3,172	3,561	2,487	2,891	2,755
Cash Equivalents	-25.7%	1,494	2,011	1,000	1,289	1,351
Inventory	3.2%	586	568	559	518	465
Net PPE	-0.8%	1,082	1,091	1,068	1,055	1,034
Goodwill	0%	3,239	3,239	3,238	7,158	7,113
Current Liabilities	-19.6%	2,230	2,773	2,669	2,881	1,490
LT Debt, Current	-	499	-	-	-	-
Shareholder's Equity	1.4%	6,693	6,599	6,731	10,444	10,895
Retained Earnings	0.3%	1,145	1,142	1,281	5,097	5,632
Additional Paid-In Capital	1.1%	9,311	9,207	9,129	9,033	8,957
Accumulated Depreciation	-	962	-	-	-	-
Shares Outstanding	0.6%	158	157	157	157	-

* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	-41.3%	230	392	527	307	435
Share Based Compensation	0.3%	367	366	364	790	779
Cashflow From Investing	3.0%	-573	-591	-489	-2,687	-2,519
Cashflow From Financing	-49.4%	506	1,000	-85.00	-507	-998
Buy Backs	-	0.00	-	-	-	-

Risks for ILMN

What is the probability of a big loss on ILMN?

90%

Probability that Illumina stock will be more than 20% underwater in next one year

44.6%

Probability that Illumina stock will be more than 30% underwater in next one year.

22.3%

Probability that Illumina stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ILMN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Illumina was unfortunately bought at previous high price.

Drawdowns

Returns for ILMN

Cumulative Returns on ILMN

10.6%

10-Year Cumulative Returns

4.5%

7-Year Cumulative Returns

-5.9%

5-Year Cumulative Returns

-17.9%

3-Year Cumulative Returns

What are the long-term rolling returns for ILMN?

FIve years rolling returns for Illumina.

Annualized Returns

Which funds bought or sold ILMN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-23	BROOKFIELD Corp /ON/	sold off	-100	-2,875,490	-	-%
2023-05-23	Front Row Advisors LLC	unchanged	-	2,000	16,000	0.01%
2023-05-23	Toroso Investments, LLC	added	112	2,219,000	3,754,000	0.06%
2023-05-22	FDx Advisors, Inc.	unchanged	-	-	21,682,000	0.94%
2023-05-22	AMERIPRISE FINANCIAL INC	added	1.57	22,405,500	155,410,000	0.05%
2023-05-22	PUTNAM INVESTMENTS LLC	added	533	25,377,500	29,415,000	0.05%
2023-05-22	PUTNAM INVESTMENTS LLC	sold off	-100	-349,683	-	-%
2023-05-19	Coppell Advisory Solutions LLC	sold off	-100	-6,066	-	-%
2023-05-19	Geo Capital Gestora de Recursos Ltd	sold off	-	-	-	-%
2023-05-18	NEW YORK STATE COMMON RETIREMENT FUND	sold off	-100	-7,807,000	-	-%

Latest Funds Activity

Are funds buying ILMN calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own ILMN

No. of Funds

Illumina News

Schedule 13G FIlings of Illumina

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	edgewood management llc	4.1%	6,478,370	SC 13G/A
Feb 09, 2023	vanguard group inc	8.28%	13,022,627	SC 13G/A
Jan 31, 2023	blackrock inc.	7.7%	12,051,653	SC 13G/A
Jan 20, 2023	baillie gifford & co	10.64%	16,743,103	SC 13G/A
Feb 14, 2022	edgewood management llc	5.6%	8,742,202	SC 13G
Feb 03, 2022	blackrock inc.	7.5%	11,784,218	SC 13G/A
Jan 20, 2022	baillie gifford & co	13.10%	20,480,537	SC 13G/A
Feb 16, 2021	capital research global investors	0.2%	257,847	SC 13G/A
Feb 10, 2021	vanguard group inc	7.76%	11,330,232	SC 13G/A
Jan 29, 2021	blackrock inc.	7.7%	11,253,386	SC 13G/A

ILMN Fair Value

Illumina fair value in different scenarios

The table shows the Fair Value estimates for Illumina for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	- -	- -	- -	- -	- -
Current Inflation	35.56 -81.85%	45.85 -76.59%	61.27 -68.72%	82.03 -58.12%	94.65 -51.68%
Very High Inflation	- -	- -	- -	- -	- -

Historical Illumina Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Illumina

View All Filings

Date Filed	Form Type	Document
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	8-K	Current Report
May 24, 2023	4	Insider Trading
May 22, 2023	144	Notice of Insider Sale Intent
May 19, 2023	DFAN14A	DFAN14A
May 18, 2023	DEFA14A	DEFA14A
May 17, 2023	DEFA14A	DEFA14A
May 15, 2023	DEFA14A	DEFA14A
May 15, 2023	DFAN14A	DFAN14A

Latest Insider Trading transactions for ILMN

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-22	TOUSI SUSAN H	sold	-1,042,970	208	-5,000	svp, chief commercial officer
2023-05-05	Frank John Edward	sold (taxes)	-20,764	199	-104	chief public affairs officer
2023-04-05	Pegels Kevin Carl	sold (taxes)	-28,865	230	-125	chief of global operations
2023-04-05	Rollins Carissa	sold (taxes)	-26,555	230	-115	svp, chief information officer
2023-03-31	Gottlieb Scott	acquired	21,047	210	100	-
2023-03-01	Hoyt Aimee L	acquired	-	-	6,926	svp, chief people officer
2023-03-01	TOUSI SUSAN H	acquired	-	-	10,074	svp, chief commercial officer
2023-03-01	Frank John Edward	acquired	-	-	7,556	chief public affairs officer
2023-03-01	Aravanis Alexander	acquired	-	-	10,074	svp, chief technology officer
2023-03-01	GOSWAMI JOYDEEP	acquired	-	-	10,074	svp chief financial officer

About Illumina

Francis A. deSouza

www.illumina.com

9800

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

ILMN Income Statement

2023-04-02

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Apr. 02, 2023	Apr. 03, 2022
Revenue:
Total revenue	$ 1,087	$ 1,223
Cost of revenue:
Amortization of acquired intangible assets	48	40
Total cost of revenue	432	408
Gross profit	655	815
Operating expense:
Research and development	341	323
Selling, general and administrative	378	308
Total operating expense	719	631
(Loss) income from operations	(64)	184
Other income (expense):
Interest income	17	0
Interest expense	(20)	(6)
Other expense, net	(11)	(38)
Total other expense, net	(14)	(44)
(Loss) income before income taxes	(78)	140
(Benefit) provision for income taxes	(81)	54
Net income	$ 3	$ 86
Earnings per share:
Basic (in dollars per share)	$ 0.02	$ 0.55
Diluted (in dollars per share)	$ 0.02	$ 0.55
Shares used in computing earnings per share:
Basic (in shares)	158	157
Diluted (in shares)	158	159
Product revenue
Revenue:
Total revenue	$ 922	$ 1,070
Cost of revenue:
Cost of revenue	285	299
Service and other revenue
Revenue:
Total revenue	165	153
Cost of revenue:
Cost of revenue	$ 99	$ 69

ILMN Balance Sheet

2023-04-02

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Apr. 02, 2023	Jan. 01, 2023
Current assets:
Cash and cash equivalents	$ 1,494	$ 2,011
Short-term investments	24	26
Accounts receivable, net	665	671
Inventory, net	586	568
Prepaid expenses and other current assets	403	285
Total current assets	3,172	3,561
Property and equipment, net	1,082	1,091
Operating lease right-of-use assets	658	653
Goodwill	3,239	3,239
Intangible assets, net	3,237	3,285
Other assets	423	423
Total assets	11,811	12,252
Current liabilities:
Accounts payable	242	293
Accrued liabilities	1,239	1,232
Term notes, current portion	0	500
Convertible senior notes, current portion	749	748
Total current liabilities	2,230	2,773
Operating lease liabilities	747	744
Term notes	1,487	1,487
Other long-term liabilities	654	649
Stockholders’ equity:
Common stock	2	2
Additional paid-in capital	9,311	9,207
Accumulated other comprehensive (loss) income	(1)	3
Retained earnings	1,145	1,142
Treasury stock, at cost	(3,764)	(3,755)
Total stockholders’ equity	6,693	6,599
Total liabilities and stockholders’ equity	$ 11,811	$ 12,252